SLC22A2 and polycystic ovary syndrome: Higher C-peptide levels at baseline and after glucose load found in patients with at least one mutant allele in SLC22A1 and SLC22A2 polymorphisms (p < 0.05). This hold true in a subsequent grouping among PCOS lean group (p =0.007).